Background-Although cardiac output (CO) plays the vital role of delivering nutrients to body tissues, few data are available concerning the relations of stroke volume (SV) and CO to body composition in large population samples. Methods and Results-Doppler and 2D echocardiography and bioelectric impedance in 2744 Strong Heart Study participants were used to calculate SV and CO and to relate them to fat-free body mass (FFM), adipose mass, and demographic variables. Both SV and CO were higher in men than women and in overweight than normal-weight individuals, but these differences were diminished or even reversed by normalization for FFM or body surface area. In both sexes, SV and CO were more strongly related to FFM than adipose mass, other body habitus measures, arterial pressure, diabetes, or age. In multivariate analyses using the average of Doppler and left ventricular SV to minimize measurement variability, FFM was the strongest correlate of SV and CO; other independent correlates were adipose mass, systolic pressure, diabetes, age, and use of digoxin and calcium channel and ␤-blockers. Conclusions-In a population-based sample, SV and CO are more strongly related to FFM than other variables; increased FFM may be the primary determinant of increased SV and CO in obesity. (Circulation. 2001;103:820-825.)
T he association between obesity and cardiac output (CO) has been observed since the 1950s, when Alexander et al 1 characterized obesity as a state in which elevated blood volume, enlarged vascular tree, and increased CO were all thought necessary to sustain the metabolic demands of an expanded adipose tissue mass. Messerli et al 2 later confirmed increases in intravascular volume in obese subjects and demonstrated that this elevation of CO was related primarily to increases in stroke volume (SV) rather than in heart rate. The observed changes in total blood volume and CO were again assumed to be secondary to metabolic demands of excess adipose tissue. 2, 3 Overweight, however, is also associated with increased fatfree mass (FFM), 4 and the relative contributions of adipose body mass and FFM as determinants of CO have not been studied to date. Because FFM represents metabolically active tissue and because the increased weight in obese individuals is in part due to increased FFM, the present study was undertaken to test the hypothesis that FFM is a stronger determinant of SV and CO than adipose mass or other clinical characteristics. An additional goal was to determine whether differences in FFM between overweight and normal-weight adults might account for the increased CO in the former group.
Methods
The Strong Heart Study (SHS) is a population-based survey of cardiovascular risk factors and prevalent and incident cardiovascular disease in American Indian communities in Arizona, Oklahoma, and South and North Dakota. As previously described, [5] [6] [7] members of 3 tribal communities in Arizona, 7 in Oklahoma, and 3 in South/North Dakota, 45 to 74 years old, were recruited from tribal members living on reservations or (in Oklahoma) in a defined geographic area (overall participation rate 62%) for an initial examination in 1989 to 1992.
The second SHS examination was conducted in 1993 to 1995 to assess change in body habitus, blood pressure, and other baseline measures and to add echocardiography among surviving participants. 7 Standardized measurements of seated brachial blood pressure; anthropometric measures, including height, weight, body mass index (BMI), waist/hip ratio, and percent body fat by bioelectric impedance; fasting glucose, insulin, lipid, and lipoprotein concentrations; and 2-hour glucose tolerance test and glycosylated hemoglobin levels were obtained. Diabetes was diagnosed by World Health Organization criteria. 8 FFM and adipose body mass were estimated by use of an RJL impedance meter 5 
Adipose body massϭweightϪFFM.
Assessment of FFM by bioelectric impedance has been validated in American Indians by comparison with FFM determined by underwater weighing alone or in combination with dual-energy x-ray absorptiometry (rϭ0.86 to 0.97). 9, 10 To calculate waist/hip ratio, waist circumference was measured in the supine position with an anthropometric tape; hip circumference was measured at the maximum protrusion of the gluteal muscles in the standing position. Overweight was recognized by BMIϾ27.3 kg/m 2 in men and 27.8 kg/m 2 in women.
For the present study, participants were included if they had technically satisfactory Doppler echocardiographic measurements of SV, CO, and bioelectric impedance measurements and no hemodynamically significant (Ն2ϩ) aortic or mitral regurgitation by color Doppler echocardiography.
Echocardiographic Methods
Studies were performed by a protocol previously described in detail 11, 12 using phased-array echocardiographs with M-mode, 2D, and pulsed and color-flow Doppler capabilities. Subjects were examined with the head of the examining table elevated Ϸ30°in the partial decubitus position. Pulsed Doppler sample volumes were placed at the center of the aortic annulus in the apical long-axis or "five-chamber" view to record systolic transaortic blood flow.
Echocardiographic Measurements
Correct orientation of planes for imaging and Doppler recordings was verified as previously described. 13 Measurements were made with computerized review stations equipped with digitizing tablet and monitor screen overlay for calibration and measurement. Left ventricular (LV) internal dimension and septal and posterior wall thicknesses were measured at end diastole and end systole by American Society of Echocardiography (ASE) M-mode recommendations 14 on up to 3 cardiac cycles. When optimal orientation of the LV cursor could not be obtained, correctly oriented linear dimension measurements were made by the ASE 2D leading-edge convention. 15 The diameter of the aortic annulus was measured in the long-axis view that maximized it from trailing edge to leading edge at the hinging points of the aortic cusps to the annulus, with color Doppler used to clarify tissue-blood interfaces if necessary. 16 Doppler transaortic flow was assessed in the projection in which peak flow velocity was maximal by tracing the black-white interface outlining the Doppler flow envelope, as previously shown to yield accurate estimates of invasively measured SV. 17 Heart rate was measured simultaneously. Doppler color-flow maps and, when applicable, pulsed-wave recordings were used to grade mitral and aortic regurgitation on a scale of 0 to 4ϩ by standard criteria. 18, 19 
Calculation of Derived Variables
Doppler SV was calculated as aortic annular cross-sectional area (in square centimeters) times the aortic time-velocity integral in centimeters. CO was derived as SV times heart rate. SV was also measured from LV end-diastolic and end-systolic volumes calculated from LV internal dimensions by a method validated in individuals with normal-sized to dilated LVs. 20 To assess whether reducing the variability of SV and CO by averaging results of 2 measurements would strengthen their relations to body habitus and other variables, "average" SV and CO were calculated as the mean of Doppler and LV measurements.
Data Handling and Statistical Analyses
Data are presented as meanϮSD for continuous variables and proportions for categorical variables. Because of the known impact of sex on body composition, analyses were performed separately in men and women. Partial correlations between independent variables and SV and CO were adjusted for possible center effects by use of 2 dummy variables. Multiple linear regression analysis using an enter procedure with assessment of collinearity diagnostics was used to determine the independence of correlates of SV and CO. Measures of body composition considered in these analyses were FFM and adipose mass, height to the power of its allometric relations with SV and CO (height 2.04 and height 1.83 , respectively 21 ), BMI, and waist/hip ratio. Partial correlation coefficients were used to estimate the proportion of variance of dependent variables explained by each independent variable. The strength of correlations of different variables to the same reference standard was compared by use of Fisher's z statistic. Two-tailed PϽ0.05 indicated statistical significance.
Results
Technically satisfactory Doppler echocardiograms, body composition measurements, and other needed clinical data for the present study were obtained in 2744 participants in the second SHS examination without Ն2ϩ aortic or mitral regurgitation or segmental LV wall motion abnormalities ( Table 1 ). Ages of men and women ranged from 48 to 81 and 
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Fat-Free Mass, Adipose Mass, and Cardiac Output 46 to 80 years, respectively. All measures of body size, including FFM, were higher in men, whereas body adiposity was greater in women. SV and CO were higher by Ϸ10% in men; mean differences were similar for average SV and CO, with smaller SDs.
Overweight individuals were younger, heavier, and had higher adipose mass, percent body fat, and waist/hip ratio than normal-weight participants. FFM was higher, by a mean of 14%, and SV and CO were Ϸ9% higher in overweight individuals. Use of average values of SV and CO resulted in nearly identical mean differences between groups with smaller SDs.
Correlates of SV
In men, SV correlated better with FFM than with adipose mass, BMI, waist/hip ratio, height, or height 2.04 ( Table 2) . SV had a weak positive relation with systolic pressure and a weak negative one with age. Body weight was as strong a correlate of SV as FFM. Average SV had a similar pattern of relationships, with generally slightly higher correlation coefficients.
In women, SV was moderately and equivalently correlated with FFM, adipose mass, body weight, and BMI. Weaker, but still significant, positive relations were ob-served between SV and waist/hip ratio, height and height 2.04 , and systolic pressure but not age. Average SV had a minimally stronger set of relations with body habitus variables and SV. SV (as well as CO) was higher (PϽ0.001) in diabetic women.
Correlates of CO
In men, CO was more closely correlated with FFM than adipose mass, waist/hip ratio, height, or height 1.83 (Table 3) . Relations of CO with body weight and BMI, however, were similar to that with FFM. CO also had a weak positive relation with systolic pressure and a weak negative one with age. Average CO was correlated slightly more closely with most measures of body size and systolic pressure. CO was higher in diabetic than nondiabetic men (mean, 5.3 versus 5.0 L/min, PϽ0.001) because of higher heart rate.
Among women, CO had similar moderate, positive relations with FFM and body weight and slightly weaker ones with adipose mass and BMI. Positive, but more weakly positive, relations were observed between CO and waist/hip ratio, height, height 1.83 , and systolic pressure but not age. Use of average CO slightly strengthened most relations, except those with height. 
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Multivariate Analyses SV had the strongest independent positive correlation with FFM, followed by adipose mass, in both sexes ( Table 4 ). Diabetes had an independent negative relation with SV in men, with a parallel trend in women; systolic pressure had a weak positive relation to SV in women, with a parallel trend in men; age did not enter the model in either sex. When women and men were considered together, with an indicator variable for sex, larger SV was independently related to higher FFM (␤ϭ0.333), adipose mass (␤ϭ0.181), absence of diabetes (␤ϭϪ0.081), and higher systolic pressure (␤ϭ0.061, all PϽ0.001) but not age or sex.
Alternative analyses used average SV as the dependent variable. In men, the multiple R increased from 0.31 to 0.39 because of stronger associations with FFM (␤ϭ0.286), adipose mass (␤ϭ0.148), and absence of diabetes (␤ϭϪ0.138) (all PϽ0.001) but not age or systolic pressure. In women, the multiple R also increased (0.44 versus 0.41), principally because of stronger association with FFM (␤ϭ0.285), with smaller increases in associations with adipose mass (␤ϭ0.198), systolic pressure (␤ϭ0.092), and absence of diabetes (␤ϭϪ0.073) but not age. When women and men were considered together, the multiple R increased slightly (from 0.39 and 0.44 in the 2 sexes to 0.48), with average SV most strongly associated with higher FFM (␤ϭ0.416), followed by higher adipose mass (␤ϭ0.181) and systolic pressure (␤ϭ0.083) and absence of diabetes (␤ϭϪ0.107) (all PϽ0.001). In further analysis considering major cardioactive medications, SV was independently related (Rϭ0.51) to FFM (␤ϭ0.419), adipose mass (␤ϭ0.219), absence of diabetes (␤ϭ0.094), higher systolic pressure (␤ϭ0.087) (all PϽ0.001), and use of digoxin (␤ϭ0.061, Pϭ0.002) and calcium blockers (␤ϭ0.060, Pϭ0.003) but not sex, age, or use of diuretics, ACE inhibitors, or ␤-blockers.
Sex-specific regression analyses to identify independent correlates of CO are summarized in Table 5 . In both sexes, FFM was the strongest correlate of CO. Adipose mass was the second strongest correlate of CO in women but was not independently associated with it among men. In both sexes, systolic pressure was positively associated with CO, whereas age and diabetes were not. When the sexes were combined, CO was most strongly (Rϭ0.39) associated with FFM (␤ϭ0.304), followed by adipose mass (␤ϭ0.159) and systolic pressure (␤ϭ0.092, all PϽ0.001) but not age, diabetes, or sex.
Alternative regression analyses used average CO as the dependent variable. The multiple R increased slightly in women (Rϭ0.42 versus 0.39), principally because of the stronger association with FFM (␤ϭ0.292, PϽ0.001), with minimal changes in associations with adipose mass (␤ϭ0.137, PϽ0.001) and systolic pressure (␤ϭ0.087). In men, multiple R increased modestly (0.39 versus 0.34) because of stronger positive associations of CO with FFM (␤ϭ0.257) and systolic pressure (␤ϭ0.124, both PϽ0.001) and stronger negative association with age (␤ϭϪ0.098, Pϭ0.004), with unchanged positive association with adipose mass (␤ϭ0.096, Pϭ0.021). When the sexes were combined, CO had positive relations to FFM (␤ϭ0.372), adipose mass (␤ϭ0.145), and systolic pressure (␤ϭ0.105; all PϽ0.0001) and a negative one with age (␤ϭϪ0.054, Pϭ0.004) but not diabetes or sex (Rϭ0.43). In further analysis that also considered cardioactive medications, CO was independently related (Rϭ0.46) to FFM (␤ϭ0.368), adipose mass (␤ϭ0.171), systolic pressure (␤ϭ0.102) (all PϽ0.001), calcium blocker use (␤ϭ0.072) and absence of ␤-blocker use (␤ϭϪ0.071) (both Pϭ0.001), younger age (␤ϭ0.050, Pϭ0.024), and digoxin use (␤ϭ0.044) but not sex, diabetes, or diuretic or ACE inhibitor use.
Associations of Sex and Obesity With Different Normalizations of SV and CO
Absolute SV and CO were higher in men than women, whereas normalization for body surface area eliminated the sex difference in SV and resulted in marginally higher cardiac index in women (Table 6 ). SV and CO normalized for FFM were considerably smaller in men than women. Average SV and CO had virtually identical mean sex differences, with smaller within-group SDs.
Overweight participants had higher absolute SV and CO than nonoverweight participants, whereas these differences were eliminated by normalization for body surface area and reversed by indexation by FFM. These findings were confirmed in analyses using averaged Doppler and LV determinations of SV and CO.
Discussion
To the best of our knowledge, this is the first study to examine the relations of SV and CO to FFM and adipose mass in a large population sample. The principal finding of the study is that both SV and CO are more strongly related to FFM than to adipose mass, other anthropometric measures, These results, although new, are not surprising in view of studies demonstrating increased FFM in obese individuals in a variety of populations and age groups: FFM accounts for 20% to 40% (average, 29%) of the weight difference between lean and overweight groups. 4 Consistent with these observations, FFM accounted for 6.8 kg, or 30%, of the 22.5 kg greater body weight in overweight than normal-weight SHS participants.
Results of Multivariate Analyses
When both sexes were combined, with addition of an indicator variable for sex, Doppler SV was most strongly related to FFM, with associations, as judged by standardized regression coefficients (␤), Ϸ67% as strong with adipose body mass and 25% as strong with systolic pressure and absence of diabetes. Neither sex nor age was independently associated with Doppler SV in this model.
In a similar analysis, CO was most strongly related to FFM, with additional associations Ϸ50% as strong with adipose mass and Ϸ25% as strong with systolic blood pressure and absence of diabetes but not sex or age. These observations are in accord with previous evidence that different normal limits for indexed SV or CO are not needed in relation to either sex or age among adults. 21
Impact of Using Average of Doppler and LV Measurements
One problem in assessing the determinants of many physiological measurements, exemplified by arterial pressure, is considerable between-measurement variability. Although use of many measurements is optimal, 22 up to a 30% reduction in variability can be obtained by using one additional measurement. In the present study, we took advantage of the fact that our protocol provides separate measurements of SV by validated Doppler and LV methods 11, 17 to calculate average SV and, consequently, average CO. As expected, average SV and CO showed lower within-group variability and had somewhat stronger relations than primary Doppler measurements with body habitus variables. Of greatest biological importance, use of averaged measures of cardiac pump function increased the disparity between FFM and adipose mass as independent determinants thereof. Additional consideration of medication usage confirmed these results and revealed independent associations between digoxin or calcium blockers and SV (with mean increments of ϩ5.9 and ϩ2.2 mL) and between digitalis, calcium blockers, and ␤-blockers and cardiac index (by ϩ357, ϩ234, and Ϫ356 mL · min Ϫ1 · m Ϫ2 on average).
Physiological Mechanisms
FFM (comprising organ cell mass and nonfatty tissues, including tendons, ligaments, and bone) 23 represents metabolically active tissue; up to 99% of body metabolism takes place in the body cell mass. 24 Given that CO is known to be intimately related to the level of metabolism, through tissue demands for oxygen, 25 it is tempting to ascribe the importance of FFM as a correlate of CO in both lean and obese subjects to the "metabolic load" accompanying FFM and to attribute part of the increased CO of obesity to increased FFM associated with obesity.
In addition to associations between FFM and SV and CO, the present study has also shown the latter variables to be more weakly associated with adipose mass. These associations may reflect blood flow needed to support the energy expenditure, albeit small, of adipose tissue as well as possible shunt flow through this tissue and increased cutaneous blood flow to dissipate body heat in overweight individuals. In addition, despite reasonable accuracy of bioelectric impedance FFM measurements, residual errors may have attributed some FFM to adipose mass, thereby overestimating the associations of adipose mass with CO. One important result of the present study is that only a small portion of variability of SV and CO is associated with and thus potentially explained by body composition and demographic characteristics that were considered, with R 2 values ranging from 0.10 to 0.26 in multivariate analyses. Because the factor associated with resting CO that is most strongly physiologically regulated is matching oxygen delivery to tissue needs, the CO needed for a given level of tissue metabolism will be inversely related to blood hemoglobin concentration. It is attractive to speculate that higher SV and CO indexed for FFM in women than men may have been a compensation for lower hemoglobin concentration in women. 26 Unfortunately, hemoglobin was not measured in the present study.
